Industry

DUBLIN–(BUSINESS WIRE)–The “Patient Warming Devices – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Patient Warming Devices estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2026, growing at a CAGR of 5.5% over the analysis period. … [Read more…]

NATICK, Mass.–(BUSINESS WIRE)–#ASCO2022–Naveris, Inc. announces the presentation of an abstract related to its flagship diagnostic test for TTMV-HPV DNA (NavDx®) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting taking place from June 3 through June 7, 2022 in Chicago and virtually. Results of TTMV-HPV DNA testing in the NRG-HN002 phase II clinical … [Read more…]

Data presentations provide key updates on the portfolio, including Botulinum Toxin, Belotero®, Radiesse® and Ultherapy® FRANKFURT, Germany–(BUSINESS WIRE)–Merz Aesthetics today confirmed its commitment as a global leader in medical aesthetics at the 2022 International Master Course on Aging Science (IMCAS) World Congress, with the presentation of data from its medical aesthetics portfolio and a clear … [Read more…]

Anti-CD39 monoclonal antibody IPH5201 advances to Phase 2 study in lung cancer Innate to receive $5M milestone payment from AstraZeneca MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that IPH5201, an anti-CD39 blocking monoclonal antibody developed in collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), will advance into … [Read more…]

BUENA PARK, Calif.–(BUSINESS WIRE)–#TheProcessor–On Sunday June 5 from 11.00am to 3.30pm Sun West will proudly support the TACA (The Autism Community in Action) Family Carnival at Oak Canyon Park 5305 Santiago Canyon Rd, Silverado CA 92676. A day of fun and community for families caring for children and youth in a secure and safe environment. … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements. Dr. John F. Burd, Ph.D., CEO of Lysulin, said, “Lysulin is pleased to report that we have resolved the issues raised by … [Read more…]

Connection, Partnership, & An Agent for Change NORFOLK, Va.–(BUSINESS WIRE)–Grant Lottering and Unite Health Share Ministries (UHSM), a faith-based health care nonprofit dedicated to a holistic approach to one’s health, have positively impacted children on behalf of nonprofit Laureus Sport for Good USA. Together, their missions emphasize a wellness approach that focuses on the mind-body-and-soul … [Read more…]

The $16.4 Million Development Serves People Living with HIV AUSTIN, Texas–(BUSINESS WIRE)–Prosperity Bank and the Federal Home Loan Bank of Dallas (FHLB Dallas) awarded a $750,000 Affordable Housing Program (AHP) subsidy to build an affordable apartment complex for people living with HIV in Austin, Texas. Scurry Miller, executive director of Project Transitions Inc., said stable … [Read more…]

Program helps identify biomarkers of non-small cell lung cancer and potential targeted treatments or clinical trials BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, understands the important and growing role of precision medicine and is working to ensure more people have access to targeted and personalized treatments. As part of this effort, … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, effective on May 23, 2022 and May 31, 2022, respectively (the “Grant Dates”), the Compensation Committee of Precision’s Board of Directors approved the grant of inducement … [Read more…]